These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

594 related articles for article (PubMed ID: 23617329)

  • 21. SIRT3 regulates mitochondrial protein acetylation and intermediary metabolism.
    Hirschey MD; Shimazu T; Huang JY; Schwer B; Verdin E
    Cold Spring Harb Symp Quant Biol; 2011; 76():267-77. PubMed ID: 22114326
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sirtuin chemical mechanisms.
    Sauve AA
    Biochim Biophys Acta; 2010 Aug; 1804(8):1591-603. PubMed ID: 20132909
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of NAD(+) in the deacetylase activity of the SIR2-like proteins.
    Landry J; Slama JT; Sternglanz R
    Biochem Biophys Res Commun; 2000 Nov; 278(3):685-90. PubMed ID: 11095969
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dynamics of NAD-metabolism: everything but constant.
    Opitz CA; Heiland I
    Biochem Soc Trans; 2015 Dec; 43(6):1127-32. PubMed ID: 26614649
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Players in ADP-ribosylation: Readers and Erasers.
    Verheugd P; Bütepage M; Eckei L; Lüscher B
    Curr Protein Pept Sci; 2016; 17(7):654-667. PubMed ID: 27090904
    [TBL] [Abstract][Full Text] [Related]  

  • 26. ADP-Ribosylation, a Multifaceted Posttranslational Modification Involved in the Control of Cell Physiology in Health and Disease.
    Lüscher B; Bütepage M; Eckei L; Krieg S; Verheugd P; Shilton BH
    Chem Rev; 2018 Feb; 118(3):1092-1136. PubMed ID: 29172462
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Regulation of glutamate dehydrogenase by reversible ADP-ribosylation in mitochondria.
    Herrero-Yraola A; Bakhit SM; Franke P; Weise C; Schweiger M; Jorcke D; Ziegler M
    EMBO J; 2001 May; 20(10):2404-12. PubMed ID: 11350929
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Protein ADP-ribosylation in rat liver cytosol.
    Skala H; Vibert M; Weber A; Kahn A; Dreyfus JC
    Biochem Int; 1983 Dec; 7(6):747-54. PubMed ID: 6091660
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Niacin status, NAD distribution and ADP-ribose metabolism.
    Kirkland JB
    Curr Pharm Des; 2009; 15(1):3-11. PubMed ID: 19149597
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of oxidative stress on in vivo ADP-ribosylation of eukaryotic elongation factor 2.
    Bektaş M; Akçakaya H; Aroymak A; Nurten R; Bermek E
    Int J Biochem Cell Biol; 2005 Jan; 37(1):91-9. PubMed ID: 15381153
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Regulatory Effects of NAD
    Zhang N; Sauve AA
    Prog Mol Biol Transl Sci; 2018; 154():71-104. PubMed ID: 29413178
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mitochondrial Sirtuin Network Reveals Dynamic SIRT3-Dependent Deacetylation in Response to Membrane Depolarization.
    Yang W; Nagasawa K; Münch C; Xu Y; Satterstrom K; Jeong S; Hayes SD; Jedrychowski MP; Vyas FS; Zaganjor E; Guarani V; Ringel AE; Gygi SP; Harper JW; Haigis MC
    Cell; 2016 Nov; 167(4):985-1000.e21. PubMed ID: 27881304
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The human NAD metabolome: Functions, metabolism and compartmentalization.
    Nikiforov A; Kulikova V; Ziegler M
    Crit Rev Biochem Mol Biol; 2015; 50(4):284-97. PubMed ID: 25837229
    [TBL] [Abstract][Full Text] [Related]  

  • 34. NAD Precursors, Mitochondria Targeting Compounds and ADP-Ribosylation Inhibitors in Treatment of Inflammatory Diseases and Cancer.
    Poltronieri P; Mezzolla V; Farooqi AA; Di Girolamo M
    Curr Med Chem; 2021; 28(41):8453-8479. PubMed ID: 33461448
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Side chain specificity of ADP-ribosylation by a sirtuin.
    Fahie K; Hu P; Swatkoski S; Cotter RJ; Zhang Y; Wolberger C
    FEBS J; 2009 Dec; 276(23):7159-76. PubMed ID: 19895577
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nicotinamide adenine dinucleotide homeostasis and signalling in heart disease: Pathophysiological implications and therapeutic potential.
    Mericskay M
    Arch Cardiovasc Dis; 2016 Mar; 109(3):207-15. PubMed ID: 26707577
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nonenzymic ADP-ribosylation of specific mitochondrial polypeptides.
    Hilz H; Koch R; Fanick W; Klapproth K; Adamietz P
    Proc Natl Acad Sci U S A; 1984 Jul; 81(13):3929-33. PubMed ID: 6588374
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sir2 protein deacetylases: evidence for chemical intermediates and functions of a conserved histidine.
    Smith BC; Denu JM
    Biochemistry; 2006 Jan; 45(1):272-82. PubMed ID: 16388603
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sirtuins: NAD(+)-dependent deacetylase mechanism and regulation.
    Sauve AA; Youn DY
    Curr Opin Chem Biol; 2012 Dec; 16(5-6):535-43. PubMed ID: 23102634
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Enzymatic assays for NAD-dependent deacetylase activities.
    Landry J; Sternglanz R
    Methods; 2003 Sep; 31(1):33-9. PubMed ID: 12893171
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 30.